empr.comMPR

","in_view_percentage":"25","interstitial":""}; var hmBibblio = {"recommendationKey":"9dabde4a-1350-4f68-9b6d-88e9045d88ca","defaultImageUrl":"https:\/\/www.empr.com\/wp-content\/uploads\/sites\/7\/2020\/05\/_400x300.jpg","hide_in_article_module":"on","hide_in_article_carousel_module":null,"syndication":"off","syndicationshuffle":"off","siteprefix":"E","syndicationhomepage":"off","accessToken":"e72e766b1f3eeda302f9c08d7ad4980ef4b89d3e","tokenType":"Bearer","expiresIn":248,"expiration":1715660783}; var hmCCM = {"version":"1.1.48"}; var hmEloqua = {"eloqua_account":"2255121","eloqua_domain":"track.info.empr.com"}; var hmMprChild = {"version":"0.1.100"}; var yoastHelper = {"state":"activated"}; var hmBibblioDailyRecos = {"pluginUrl":"https:\/\/www.empr.com\/wp-content\/plugins\/hm-bibblio-manager","brandPrimary":"#FF0000","siteLogo":"","loginRedirectUrl":"https:\/\/www.empr.com\/wp-login.php?redirect_to=%2F%3FNID%3D1215923198%26c_id%26cpn%26dl%3D0%26email_hash%3D49d196b391aae6f8561f8e6c7736c211%26hmEmail%3DbNNwFdsdXAN-AEgJZXY6RA2%26hmSubId%3Dg-rZPkqOXRQ1%26mpweb%3D1323-170886-7430533"}; var hmCustomBlocksInfo = {"pluginDirPath":"\/nas\/content\/live\/haymarketwp\/wp-content\/plugins\/hm-custom-blocks\/","pluginDirUrl":"https:\/\/www.empr.com\/wp-content\/plugins\/hm-custom-blocks\/"}; var hmBibblioInArticle = {"siteTitle":"","publication_id":13,"publication_name":"","isInfiniteScroll":false}; var hmBibblioFrontend = {"postId":"220333","isMedical":true,"isIndexed":true,"pluginUrl":"https:\/\/www.empr.com\/wp-content\/plugins\/hm-bibblio-manager"}; var oracleInfinityTag = {"inifinityParams":{"hm.prefix":"omn","hm.publicationId":"13","hm.nht":"true","hm.pageType":"home","hm.pageGatingType":"none","hm.pageName":"Petosemtamab Gets Breakthrough Therapy Status for Head and Neck Cancer"},"customKey":"hm."}; var mainLocalized = {"environment":"production","debug":false,"home_url":"https:\/\/www.empr.com\/","publication_id":13,"sso":{"partial":"https:\/\/www.empr.com\/wp-json\/haymarket\/v1\/partial-login","ssoCheck":"https:\/\/accounts.haymarketmedia.com\/sso\/check\/?gn=101","ssoLogin":"https:\/\/www.empr.com\/wp-json\/haymarket\/v1\/sso-login\/?subid=SUBID","ssoLogout":"https:\/\/accounts.haymarketmedia.com\/sso\/logout\/?gn=101","disqusAuth":"https:\/\/www.empr.com\/wp-json\/haymarket\/v1\/disqus-auth"},"metering":{"content_types":[],"content_count":0,"content_type":"post","content_metered":false,"id":0,"login":" Login ","register":" Register "},"gated":{"login":" Login ","register":" Register "},"print_endpoint":"https:\/\/www.empr.com\/wp-json\/haymarket\/v1\/print-content\/","slideshow":{"previous":"Previous","next":"Next","chevron_left":" ","chevron_right":" "},"lyticsData":{"publicationId":"13","channel":"home","pagetype":"","tags":"","categories":"","pagename":"Petosemtamab Gets Breakthrough Therapy Status for Head and Neck Cancer","author":"","section":""}}; var adstackData = {"version":"2.6.27","global_targeting":{"pagetype":["post"],"sponsor":[""],"comp":[""],"author":[""],"postID":[""],"termID":"","hub":"","env":["live"],"sid":["home"],"subject":"","search":"false","styleid":[""],"cat":[""],"atype":[""],"isnht":["true"]},"dfp_network_code":"5745","dfp_ad_path":"mpr_us","dfp_lazyload":"on","dfp_interstitial_ad":"","continuous_refresh_ads":"","refresh_interval":"60","exclude_native_ad_refresh":"","refresh_all_ads":"","ism":{"enabled":""},"adDebug":false}; var aimData = {"aim_api_Key":"d734ccba-3c24-4d6d-bc64-7c5e83f8891e"}; Menu SECTIONS Home Drug Monographs Browse by brand Browse by generic Browse by therapeutic category Monograph Updates Resource Centers Allergic Disorders Cardiovascular Disease Chronic kidney disease Dermatological Disorders Diagnostic Agents Endocrine Disorders Gastrohepatic Disorders Geriatrics Hematological Disorders Immune Disorders Immunization Infectious Diseases Metabolic Disorders Musculoskeletal Disorders Neurologic Disorders Nutrition Ob/Gyn Oncology Ophthalmic Disorders Oral Health Otic Disorders Pain Management Pediatrics Poisoning & Drug Dependence Psychiatric Disorders Respiratory Disorders Urological Disorders News & Features News Drug News Alternative Medicine Safety Alerts And Recalls Biosimilars and Generics News Drugs In The Pipeline The Weekly Dose Podcast Conference Coverage Guidelines Medical Technology Healthcare Policy Features Case Studies Clinical Case Challenge Clinical Challenge Clinician POV Diagnostic Update Discussion Room Drug Primer How I Treat How to Treat Journal Club Practice, Policy & Legal Clinical Charts Tools Medical Calculators ICD-10 CME/CE App Haymarket Medical Network Cancer Therapy Advisor Clinical Advisor Clinical Pain Advisor Dermatology Advisor Endocrinology Advisor Gastroenterology Advisor Hematology Advisor Infectious Disease Advisor Medical Bag Neurology Advisor Oncology Nurse Advisor Ophthalmology Advisor Optometry Advisor Psychiatry Advisor Pulmonology Advisor Rare Disease Advisor Renal and Urology News Rheumatology Advisor Sleep Wake Advisor The Cardiology Advisor Vaccine Advisor Subscribe Part of the Search for a drug monograph: GO Drugs in the Pipeline Petosemtamab Gets Breakthrough Therapy Status for Head and Neck Cancer By Brian Park, PharmD Publish Date May 13, 2024 Petosemtamab is an investigational bispecific antibody that targets cancer cells expressing EGFR and LGR5. News More Pediatric Data Added to Labeling for Hemophilia A Therapy Altuviiio By Brian Park, PharmD Publish Date May 13, 2024 The labeling for Altuviiio [antihemophilic factor (recombinant), Fc-VWF-XTEN Fusion protein-ehtl] adding new pediatric data. Drugs in the Pipeline Vibegron Under Review for Men With OAB Symptoms Receiving BPH Treatment By Diana Ernst, RPh Publish Date May 13, 2024 Vibegron is a beta-3 adrenergic receptor agonist. News Clinolipid Approval Expanded to Include Pediatric Patients By Brian Park, PharmD Publish Date May 13, 2024 The expanded approval was based on data from 4 randomized, active-controlled, parallel-group clinical studies, which compared the efficacy and safety of Clinolipid to soybean oil-based lipid emulsions. Drugs in the Pipeline Dupilumab Gets Priority Review for Adolescents With Inadequately Controlled CRSwNP By Brian Park, PharmD Publish Date May 13, 2024 The sBLA in adolescents is supported by an extrapolation of efficacy data from the phase 3 SINUS-24 and SINUS-52 trials in adults. Guidelines , News Clinical Practice Guideline Developed for Age-Related Hearing Loss Publish Date May 13, 2024 Recommendations include ID of sociodemographic factors, patient preferences that influence access to and use of hearing health care News Disparities in Direct Oral Anticoagulant Initiation Have Declined in Recent Years Publish Date May 13, 2024 Findings seen for Black and Hispanic patients with atrial fibrillation versus White patients. News Cyberattack Cripples Major US Health Care Network Publish Date May 13, 2024 In some cases, emergency care is affected as well, with ambulances being diverted from certain medical centers. News Blood Pressure Down With Self-Monitoring of BP, Self-Titration of Medications Publish Date May 13, 2024 Reduction seen in systolic and diastolic BP with self-monitoring plus self-titration of antihypertensive medications. News , Practice, Policy, and Legal USDA, HHS Announce New Measures to Monitor, Prevent Bird Flu Publish Date May 13, 2024 Dairy farmers will be compensated for keeping workers, animals safe; viral research and monitoring will be funded. Page 1 of 4412 Page 1 Page 2 Page 3 … Page 4,412 Next page Last page Latest News Your top articles for Tuesday SIGN IN For More Personalized News Haymarket Medical Network Top Picks Loading... Continuing Medical Education (CME/CE) Courses Show More Cookie Settings ABOUT ADVERTISE CONNECT Remarkable healthcare content Cancer Therapy Advisor Clinical Advisor Clinical Pain Advisor Dermatology Advisor Endocrinology Advisor Gastroenterology Advisor Hematology Advisor Infectious Disease Advisor McKnight’s...